Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xinping Han

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Journal of Materials Chemistry. B|September 29, 2025
Design of composite strategies for metal-organic frameworks in bacterial detection and antibacterial therapy: a reviewWenyue Gao, Xinping Han, Ling Li, et al.
Marine Drugs|May 26, 2026
Sodium Alginate Hydrogel with Zinc Ion Nanoparticles for Synergistic Neuroprotection and Functional Recovery in Spinal Cord InjuryChuanxi Chi, Tianshun Ding, Xinping Han, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2023
UV-Blocking and Light-Responsive Poly (ϵ-Caprolactone)/ZIF-8 Multifunctional Composite Films for Efficient Antibacterial ActivitiesCuijuan Wang, Siwen Feng, Hongwen Tang, et al.
Journal of Materials Chemistry. B|February 28, 2025
Functionalized ZIF-8 as a versatile platform for drug delivery and cancer therapy: strategies, challenges and prospectsWenyue Gao, Xinping Han, Ling Li, et al.
Scientific Reports|June 30, 2016
Synthetic small molecule GLP-1 secretagogues prepared by means of a three-component indole annulation strategyOleg G Chepurny, Colin A Leech, Martin Tomanik, et al.
Molecular Cancer Therapeutics|August 14, 2020
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity <i>In Vitro</i> and <i>In Vivo</i>Yamini M Ohol, Michael T Sun, Gene Cutler, et al.
Journal of Medicinal Chemistry|April 18, 2020
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor ActivityPaul R Leger, Dennis X Hu, Berenger Biannic, et al.
Journal of Medicinal Chemistry|September 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Journal of Materials Chemistry. B|September 29, 2025
Design of composite strategies for metal-organic frameworks in bacterial detection and antibacterial therapy: a reviewWenyue Gao, Xinping Han, Ling Li, et al.
Marine Drugs|May 26, 2026
Sodium Alginate Hydrogel with Zinc Ion Nanoparticles for Synergistic Neuroprotection and Functional Recovery in Spinal Cord InjuryChuanxi Chi, Tianshun Ding, Xinping Han, et al.
Chemistry (Weinheim an Der Bergstrasse, Germany)|April 17, 2023
UV-Blocking and Light-Responsive Poly (ϵ-Caprolactone)/ZIF-8 Multifunctional Composite Films for Efficient Antibacterial ActivitiesCuijuan Wang, Siwen Feng, Hongwen Tang, et al.
Journal of Materials Chemistry. B|February 28, 2025
Functionalized ZIF-8 as a versatile platform for drug delivery and cancer therapy: strategies, challenges and prospectsWenyue Gao, Xinping Han, Ling Li, et al.
Scientific Reports|June 30, 2016
Synthetic small molecule GLP-1 secretagogues prepared by means of a three-component indole annulation strategyOleg G Chepurny, Colin A Leech, Martin Tomanik, et al.
Molecular Cancer Therapeutics|August 14, 2020
Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity <i>In Vitro</i> and <i>In Vivo</i>Yamini M Ohol, Michael T Sun, Gene Cutler, et al.
Journal of Medicinal Chemistry|April 18, 2020
Discovery of Potent, Selective, and Orally Bioavailable Inhibitors of USP7 with In Vivo Antitumor ActivityPaul R Leger, Dennis X Hu, Berenger Biannic, et al.
Journal of Medicinal Chemistry|September 20, 2022
Potent GCN2 Inhibitor Capable of Reversing MDSC-Driven T Cell Suppression Demonstrates In Vivo Efficacy as a Single Agent and in Combination with Anti-Angiogenesis TherapyJeffrey J Jackson, Grant M Shibuya, Buvana Ravishankar, et al.
Pageof 2